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Human platelets acutely increase mitochondrial en-
ergy generation following stimulation. Herein, a lipi-
domic circuit was uncoveredwhereby the substrates
for this are exclusively provided by cPLA2, including
multiple fatty acids andoxidized species that support
energy generation via b-oxidation. This indicates that
acute lipid membrane remodeling is required to sup-
port energetic demands during platelet activation.
Phospholipase activity is linked to energy meta-
bolism, revealing cPLA2 as a central regulator of
both lipidomics and energy flux. Using a lipidomic
approach (LipidArrays), we also estimated the total
number of lipids in resting, thrombin-activated, and
aspirinized platelets. Significant diversity between
genetically unrelated individuals and a wealth of spe-
cies was revealed. Resting platelets demonstrated
5,600 unique species, with only 50% being puta-
tively identified. Thrombin elevated 900 lipids >2-
fold with 86% newly appearing and 45% inhibited
by aspirin supplementation, indicating COX-1 is re-
quired for major activation-dependent lipidomic
fluxes. Many lipids were structurally identified. With
50% of the lipids being absent from databases, a
major opportunity for mining lipids relevant to human
health and disease is presented.
INTRODUCTION
Lipids play essential structural roles, act as nutrients, and control
a broad range of physiological and pathophysiological events in
cells. While several lipid families are well characterized at the
molecular level, the total diversity and number of unique lipids
in cells and how they change during cellular activation and differ
in individuals are unknown. This hampers integration of lipido-
mics into systems biology, and addressing it will aid (1) funda-
mental understanding of lipid biology, (2) identification of drug
targets for therapy, and (3) discovery of lipid biomarkers from930 Cell Metabolism 23, 930–944, May 10, 2016 ª 2016 The Authors
This is an open access article under the CC BY license (http://creativedisease cohorts. This is particularly relevant for identification of
low-abundance bioactive lipids that are not detected by widely
used high-throughput lipidomics.
Lipidomic methods usually target known families of lipids us-
ing mass spectrometry and do not ‘‘mine’’ the vast unknowns
contained in mass spectrometry datasets. Previous estimates
suggested mammalian cells contain 2,000–100,000, with a theo-
retical number of possible lipids at 100,000–500,000, but exper-
imental attempts to robustly define this have not been under-
taken (van Meer, 2005; Yetukuri et al., 2008). We developed a
lipidomic workflow that maximizes coverage, ensuring that
many low-abundance lipids were detected and verified (LipidAr-
rays), a step essential for discovery of signaling lipids. This
required multiple chromatographic separations, high-resolution
mass spectrometry, and in-house generation of bioinformatic
tools with both automatic and painstaking manual verification
of data.
Platelets are central players in hemostasis, have emerging
roles in cancer and immune regulation, and robustly activate lipid
metabolism during thrombin-dependent aggregation. They are
the therapeutic target of low-dose aspirin, via inhibition of cyclo-
oxygenase-1 (COX-1)-dependent formation of thromboxane
(TX). Aspirin at platelet-selective doses may prevent cancer
metastasis in humans (Langley and Rothwell, 2013; Rothwell,
2013a, 2013b), through mechanisms that could involve lipid
signaling. Last, COX-1-derived eicosanoids are mediators of
pain, cancer metastasis, fever, vasoconstriction, and platelet
activation. Thus, we sought to characterize the platelet COX-
sensitive lipidome as a model system of relevance for human
health and disease and to use this to uncover lipidomic control
networks.
Lipids were mapped under basal and thrombin-activated
conditions, with or without in vivo aspirin supplementation
(75 mg/day for 7 days). The results indicate that the human
platelet lipidome is complex and heterogeneous, with profound
changes on activation and in vivo aspirin inhibition. In particular,
192 fatty acids (FAs) and oxidized phospholipids (oxPLs) that
support coagulation were structurally identified, including
many lipids. FA formation required cytosolic phospholipaseA2
(cPLA2), which then fed into oxidative phosphorylation via
b-oxidation. The activation of cPLA2 by thrombin was also re-
vealed to be an energy-requiring process itself. Last, energy. Published by Elsevier Inc.
commons.org/licenses/by/4.0/).
(legend on next page)
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from FA oxidation was required for maintaining phospholipid
asymmetry. These data link acute lipidomic flux with meta-
bolic processes during innate immunity. Finally, the large
numbers of unknowns represent a significant opportunity for
lipid discovery.
RESULTS
Developing a Comprehensive Method to Analyze the
Complete Platelet Lipidome
To determine the complete lipidome, high-resolutionmass spec-
trometry was used to maximize detection of lipids with closem/z
values, and extensive chromatography was used to separate
isobaric species and enable detection of low-abundance lipids.
New software was generated, and datasets were also subject
to painstaking manual verification. The approach, including bio-
informatic and technical aspects, is described in full in Supple-
mental Information.
Characterizing the Size and Diversity of the Platelet
Lipidome in Three Genetically Unrelated Donors under
Basal Conditions
Three genetically unrelated volunteers provided a baseline
blood sample, and a second was provided following aspirin
ingestion (75 mg/day, 7 days). First, we identified donor-specific
total lipids at baseline. Platelets from all donors contained a
total of 8,077 lipids, of which 5,245 (65%) were common in
two or more donors. A single individual’s platelets showed
5,620 ± 436 species (mean ± SEM, n = 3; Figures 1A and 1B).
Full details of all ions detected in two or more donors are in
Data S1. A degree of variation between individuals is noted,
with each donor being 84% the same as two or more donors,
or 63.7% the same as all three (Figures 1A and 1B).
Results were queried against Human Metabolome Database
(HMDB), LipidMaps, LipidHome, and METLIN, with tolerance of
5 ppm (Figures S1A and S1B) (Foster et al., 2013; Smith et al.,
2005; Sud et al., 2007; Wishart et al., 2013). Many identified
with multiple names, in a few cases with HMDB, as many as
200–300 (Figure S1B). Thus, to putatively assign an ion to a lipid
family, we used the most common class for each. Most lipid
classes were detected in platelets, with glycerolipids (GLs)
and glycerophospholipids (PLs) predominating (Figure 1C;
Data S1). METLIN does not assign molecules to a class, thus
‘‘other metabolites (OM)’’ refers to METLIN-identified ions of
unknown class.Figure 1. The Resting Human Platelet Lipidome and How It Changes u
Platelet lipid extracts from three genetically unrelated donors (D1–D3) were anal
using SIEVE 2.0 followed by in-house-generated software as described in Suppl
(A) Venn diagram showing the number of ions in each donor lipid isolate. Comm
(B) Table showing the number of ions in each donor and mean, total and lipids c
(C) Predominant lipid classes in platelets. Ions were grouped according to the m
(D) Scatter diagrams showing elution of lipids from polar or non-polar (NP) column
classification from databases. To view in interactive mode, download Data S2, w
Putative identifications for all are in Data S1.
(E–H) The thrombin-stimulated lipidome. Platelet lipid extracts from three genet
0.2 U/mL thrombin, were analyzed as above, showing ions that are elevated at lea
(F) Total number of lipids in each donor, shown individually (G) The effect of thro
2-fold in two or more donors are shown. Out of 5,245 lipids, only 107 were upregu
(H) Scatter diagrams showing elution of lipids from polar or NP columns, in eithe
932 Cell Metabolism 23, 930–944, May 10, 2016Scatter diagrams show the range of lipids contained in plate-
lets (Figure 1D). Several lipids of unknown structure group
together, typically at higher mass ranges and hydrophobicity.
These and many other unknowns (total 51%) leave a wealth of
lipids to be discovered and characterized. To allow detailed ex-
amination of the data, we created interactive scatter diagrams
using GoogleVis that allow users to mine the unknowns, with
the ability to zoom and identify based on m/z and retention
time (Data S2). Crosschecking with Data S1 provides putative
identifications for m/z values of interest. For example, note
the large group of glycerophospholipids (PLs) in green in both
non-polar negative and non-polar positive, and glycerides
(GLs; including triglycerides) in red in the non-polar-positive
dataset.
Characterizing the Platelet Lipidome on Thrombin
Activation
Next, we examined global lipid changes on thrombin activation,
analyzing lipids that upregulate R2-fold. Thrombin caused a
selected subset of lipids to be generated, 1,550 in all three do-
nors, with 753 lipids common to two or more donors, and
mean of 914 per isolate (Figures 1E and 1F; Data S1). Of
these, 86% were absent basally and only detected on thrombin
activation (Figure 1 G). Within all upregulated lipids, 420 were
increased by >10-fold. The most predominant upregulated lipids
were putatively identified as FAs (including eicosanoids) and PLs
(Figures S1C and S1D). Principal component analysis (PCA) and
a heatmap show the diversity in thrombin responses between
donors, with samples separated in both PC1 and PC2, before
and after activation (Figures S1E and S1F). Furthermore, the
heat map (showing lipids upregulated in two or more donors)
demonstrates that each donor elevates groups of individual
lipids to different extents (Figure S1E). Scatter diagrams show
the pattern of thrombin upregulated lipids found in two or more
donors, with individual signatures shown for reference (Fig-
ure S2). FAs (purple), including eicosanoids, are strongly repre-
sented in negative mode. As for basal lipids, there are similarities
and differences between donors, in particular a prominent group
of PLs (green) in both positive and negative mode at18–25 min
in the non-polar datasets (m/z 700–900), most of which are
oxidized PLs, as shown later (Figure 1H, showing lipids present
in two or more donors). The scatter patterns appear unique to
each donor, analogous to a fingerprint (Figure S2). How they
differ in larger groups of people, and with variables including
age, gender, health, disease, and diet, will be the subject ofpon Thrombin Activation
yzed by LC-FTMS on the Orbitrap Elite, at 60,000 resolution, then processed
emental Information.
on and donor specific ions are demonstrated.
ommon to two or more donors. Calculated from (A).
ost predominant classification family based on classifications in databases.
s, in either negative- or positive-ion mode. Lipids are color-coded according to
hich allows zooming and viewing of individual accurate m/z values for all ions.
ically unrelated donors (D1–D3), before and after activation for 30 min using
st 2-fold. (E) Venn diagram thrombin-upregulated lipids in two or more donors.
mbin on basal platelet lipids. Lipids that are newly detected or elevate at least
lated, with an additional 646 appearing only in the thrombin-activated samples.
r negative- or positive-ion mode. Putative identifications for all are in Data S1.
(legend on next page)
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future study. Interactive GoogleVis scatter diagrams for these
are in Data S3.
Full Structural Identification of a Large Group of OxPLs
Generated Acutely by Thrombin-Activated Platelets
Our global analysis putatively identified several lipid families in
platelets. Given the large number of ions, full structural validation
of all is not feasible. Thus, we concentrated on mapping FAs and
PLs that are elevated on thrombin activation. We previously
found that platelets acutely generate oxPL via cyclooxygenase
(COX) and lipoxygenase (LOX), giving a total of 18molecular spe-
cies (Aldrovandi et al., 2013; Morgan et al., 2010; O’Donnell and
Murphy, 2012; O’Donnell et al., 2014; Thomas et al., 2010). Here-
in, a prominent group of ions was noted at 15–25min on the non-
polar column (green in Figure 1H) and initially assigned as PLs via
database searching. Further manual interrogation identified 111
oxPLs, indicating a large number of species (Table S2; Data S4).
Tandem mass spectrometry (MS/MS) spectra were acquired
and compared against LipidMaps and METLIN spectral data-
bases, in tandem with manual interrogation. Assignments were
based on the presence of diacyl fatty acid (sn1), oxidized
fatty acid (sn2), neutral loss of ketene with and without water,
and deprotonated precursor mass ion or loss of methyl
([M-CH3]
) for phosphatidylcholines (PCs) in negative ion
mode, andmany isobaric species are noted indicating positional
and regioisomers. To further validate, we monitored the ions in a
new donor platelet isolate, using molecular reaction monitoring
(MRM) mode on a Q-Trap platform, monitoring parent m/z to
sn2 carboxylate anion as daughter ion (Table S3). As examples,
time courses for generation of seven phosphatidylcholines (PC)
and –ethanolamines (PE) containing 22:4 and 22:5 hydroxy lipids
are shown, along with chromatograms and MS/MS spectra (Fig-
ure 2). All are virtually absent in resting platelets with immediate
rises on activation and levels sustained for at least 2 hr. The top
52 upregulated oxPLs are displayed on a radar plot, which
shows the relative abundance of specific families (Figure 3A).
Twenty-three of the top 26 are monohydroxy lipids from arachi-
donic acid (AA), docosapentanoic acid (DPA), docosahexanoic
acid (DHA), eicosapentanoic acid (EPA), and eicosatetraenoic
acid (ETrA). Less abundant aremultiple oxidized species and un-
saturated fatty acids containing more than one oxygen group.
Identification of Fatty Acids and Oxidized Fatty Acids
that Are Generated Acutely by Thrombin-Activated
Platelets
A number of lipids putatively identified as FAs in Figure 1H, with
additional ions eluting primarily on the polar-negative column,
were subject to liquid chromatography (LC) MS/MS for identifi-
cation. Of these, 81 were validated, by comparison with MS/
MS spectra at LipidMaps or HMDB, or through manual curation
(Table S4; Data S5). Many have never been detected before in
human platelets, and include saturated and unsaturated fatty
acids, known COX and LOX products, and mono/poly-oxygen-Figure 2. Time Course of Selected OxPL Generation by Human Platele
Washed platelets were activated using 0.2 U/min thrombin for varying times, th
Experimental Procedures, and with parent to daughter transitions as listed on th
standard (n = 3, mean ± SEM). Middle: sample chromatograms showing almost
MS/MS spectra for all lipids shown. More detailed MS/MS data are available in D
934 Cell Metabolism 23, 930–944, May 10, 2016ated species of unknown origin. Several had daughter ions con-
sistent with prostaglandins (PGs) or eicosanoids and include
lipids with fragmentation similar to PGB2 and PGF2a.
We highlight four, at m/z 309.1538, 307.2282, and 305.2126
(two lipids; Figures 3B and 3C). Their elemental composition
indicated four C19-monohydroxy fatty acids, with two, three,
or four double bonds, respectively. MS/MS spectra confirmed
they were structurally related, showing +2 for several daughter
ions, including m/z 205, 261, and 287 (Figure 3B; Data S5).
Three showed neutral loss of 100 amu, indicating the position
of the OH at C14. The fourth showed loss of 98 due to the
presence of a double bond distal to the OH at C14. This
indicates these to be 14-hydroxynonadecatetraenoic, -trienoic
and -dienoic acids, respectively, for m/z 305, 307, and 309
(14-HNTE, 14-HNTrE, and 14-HNDE, n-6), with an n-3 form
also found for 14-HNTE (Figure 3C). These are analogous to
12-hydroxy-5,8,10-heptadecatrienoic acid (12-HHTrE) gener-
ated by COX/thromboxane synthase oxidation of AA but
instead form via oxidation of 22:5(n6), 22:4(n6), 22:3(n6), and
22:5(n3). We also highlight dioxolane A3 (DXA3) identified via
extensive gas chromatography/mass spectrometry (GC/MS),
MS3, and biological studies as a new lipid derived from COX-1.
The complete data on this lipid will be presented elsewhere
(unpublished data). MS/MS spectra for all 81 FAs are provided
in Data S5.
Aspirin Blocks Selected Thrombin-Dependent Lipid
Mobilization in Platelets, but Responses Are Highly
Heterogeneous
To block platelet COX-1 in vivo, the same donors were adminis-
tered 75 mg/day aspirin for 7 days, then platelets were iso-
lated and activated using thrombin. Aspirin blocked TXB2 and
12-HHT generation, demonstrating donor compliance (Data
S6). Forty-five percent of thrombin-upregulated lipids were
decreased by at least 50% by aspirin consumption. Aspirin
also upregulated a small group of lipids (34 ions, 4.5%), while
just over 50% were unchanged (Figure 3D).
Given the therapeutic importance of aspirin, we focused on
suppressed ions. Forty-eight percent were absent from data-
bases, while the majority were putatively identified primarily as
FAs (Figure 3E). There were both similarities and variations in
donor responses to aspirin. To illustrate this, we focused on
the large group of fully validated FA elevated in thrombin-acti-
vated cells. Accurate mass data extracted from Orbitrap Fourier
transform mass spectrometry (FTMS) at 60,000 resolution were
manually extracted and integrated. Heatmaps show the diversity
of responses with lipids color-coded depending on class (Fig-
ure 4). As examples of divergent responses, donor 1 shows ele-
vations by aspirin alone of several unsaturated FAs (AA, DHA,
EPA, adrenic, DPA, and DTrA isomers) that is greater than the
thrombin response. In contrast, donor 2 shows low level in-
creases in a far smaller number of largely different FAs, including
some that are saturated (arachidic, palmitic, NA, palmitoleic, andts in Response to Thrombin
en lipids were extracted and analyzed using a 4000 Q-Trap as described in
e chromatograms. Left: time courses of integrated areas compared to internal
absence of lipids at 0 min followed by upregulation from 10 to 120 min. Right:
ata S4.
(legend on next page)
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EPA). Last, donor 3 shows no elevation of any FAs by aspirin.
This stimulation of FA release by aspirin in two donors occurs
in the absence of COX activation and aggregation, and the
mechanisms involved deserve further study.
In terms of oxidized FA, COX products tend to cluster with
lipids that show the greatest inhibition by aspirin, while LOX
products tend to show medium to low aspirin suppression
(Figure 4). Monohydroxy fatty acids and other oxidized lipids
are evenly spread, indicating they may originate from either
pathway.
These data are also shown using a network analysis (Cyto-
scape 3.2.1). Nodes represent individual lipids, where degree
(size) is determined by the number of links to others. Edge thick-
ness represents the strength of correlation between individual
nodes. Nodes with the highest degree clustered toward the cen-
ter. These network diagrams illustrate that while there are clear
donor variations, FA fluxes are significantly interconnected,
with a major part of the pool changing in tandem. Related lipids
cluster together, e.g., pink COX products always cluster toward
the top left, while navy blue LOX products are further right. Un-
oxidized fatty acids link together but tended to show divergent
responses to oxidized ones (Figure 4). Raw data on integration
of all these lipids are presented in Data S6 to enable comparison
of relative abundance of individual lipid species.
We also characterized the effect of aspirin on validated oxPLs,
screening the 70 that were identified by the initial Sieve analysis,
and found that the majority were unchanged or upregulated dur-
ing aspirin treatment (comparing the thrombin with thrombin +
aspirin datasets) (Data S1, tab 3). This agrees with the general
view that aspirin selectively regulates platelet aggregation, but
not coagulation.
Effect of cPLA2 Blockade on FA and OxPL Generation
Platelets express several isoforms of PLA2; thus, their role in
regulating generation of FA and oxPL families was determined
using inhibitors; for calcium-sensitive (cPLA2; cPLA2i), calcium-
insensitive PLA2 (iPLA2; bromoenol lactone [BEL]), and secretory
PLA2 (sPLA2; oleyloxyethylphosphocholine [OOEPC]). Overall,
thrombin-stimulated generation of COX, LOX products, and
FAs was effectively suppressed by cPLA2 inhibition but insensi-
tive to iPLA2 or sPLA2 blockade (Figures 5A, 5B, S3, and S4).
With cPLA2 blockade, free AA was inhibited to baseline levels
(Figures 5A and S3B). However, platelets already contain free
AA before activation, thus allowing up to 50% generation of
COX or LOX products. OxPL generation was only partially sensi-
tive to inhibition of cPLA2 but insensitive to iPLA2 blockade (Fig-
ures 5 C and S3D; individual isomers in Figure S5). Thus, suffi-Figure 3. Radar Plot ShowingRelative Levels of OxPLsGenerated byPla
and Effect of Aspirin on the Platelet Lipidome
(A) Radar plot showing time course of the 52 most upregulated oxPLs. The lipids
AA, 22:4, and 22:5 predominate (red, brown, and burgundy labels are on right-h
(B) MS/MS spectra of four lipids identified as 14-HNTE (n6), 14-HNTE (n3), 14-HNT
ion from an unrelated isobaric lipid).
(C) Mechanism of formation of 14-HNTE (n6) (left) and fragmentation of all four is
(D) Aspirin blocks generation of 45% of platelet lipids upregulated by thrombin.
7 days on 75mg/day aspirin were analyzed after activation for 30min using 0.2 U/m
2-fold in two or more donors are shown.
(E) Predominant lipid classes upregulated by thrombin and aspirin inhibited in pl
sification family based on classifications in LipidMaps, LipidHome, or HMDB, as
936 Cell Metabolism 23, 930–944, May 10, 2016cient eicosanoids are generated to allow formation oxPLs,
even in the absence of AA release. Sensitivity of oxPLs, but not
FAs, to sPLA2 inhibition was also seen (see Figure 5C for a sum-
mary and Figure S5 for all individual lipids). This suggests sPLA2
maybe the source of lyso-PL required for rapid eicosanoid ester-
ification into PL pools.
Several saturated FAs were elevated in response to thrombin,
although there was donor variability (Figure 4). These likely orig-
inate from the sn1 position of PLs andmay also be cleaved by the
cPLA2a isoform, which is known to also have PLA1 activity (Loo
et al., 1997). Platelets contain a large proportion of plasmalogen
PLs and thus would not be considered a major source of hydro-
lysable saturated FAs. Biological actions and the cellular source
of these lipids in the context of vascular health warrants further
study.
Blockade of cPLA2 Suppresses Basal- and Thrombin-
Linked Mitochondrial Respiration, Linking Lipidomic
Flux with Metabolism in Platelets
The diversity of FAs upregulated on platelet activation prompted
further investigation. FAs are substrates for mitochondrial
b-oxidation, which provides acetyl-coenzyme A for the citric
acid cycle. We recently showed that oxygen consumption in-
creases acutely on thrombin activation and is primarily sup-
ported by energy from b-oxidation (Ravi et al., 2015). Also,
b-oxidation along with glycolysis is required for full aggregation
to occur (Ravi et al., 2015). Thus, we queried if mobilization of
FAs by cPLA2 upon thrombin activation might feed into acute
regulation of mitochondrial respiration, linking lipidomic dy-
namics with acute changes in energy metabolism.
Accordingly, extracellular flux analysis showed that platelet
basal oxygen consumption rate (OCR) decreased 20% with
cPLA2i (Figure 5D). Thrombin then stimulated OCR, largely due
to increased mitochondrial FA oxidation (Ravi et al., 2015).
cPLA2i almost totally blocked thrombin stimulation of OCR
compared to control (Figures 5D and 5E). To confirm the oxida-
tive phosphorylation component, at 20–30 min, oligomycin was
injected to inhibit complex V, leading to the expected decrease
in OCR. Then, FCCP, a proton-ionophore, was injected to stim-
ulate maximal respiration, leading to an increase in maximal
OCR, but to a smaller extent in the cPLA2i-treated platelets
(Figure 5D). Finally, antimycin A was added. ATP-linked respira-
tion was calculated by subtracting OCR after oligomycin
addition from basal. As shown recently, thrombin increased
ATP-linked respiration, indicating an increased energetic
requirement for aggregation (Figure 5F) (Ravi et al., 2015).
Blockade of cPLA2 decreased this, both basally and in thetelets, Identification of FourOxidized FAsGenerated viaCOX-1/TXS,
are color-coded based on sn2 fatty acid, and show that monohydroxylipids of
and side of plot), while poly-hydroxylated FAs are less abundant.
rE (n6), and 14-HNDE (n6). Note amajor ion, identified in (C). NR, not related (an
omers (right).
Platelet lipid extracts from three genetically unrelated donors with or without
L thrombin, as in Figure 1. Ions noted in Figure 1G to be upregulated by at least
atelets. Putative ions were grouped according to the most predominant clas-
for Figure 1C.
(legend on next page)
Cell Metabolism 23, 930–944, May 10, 2016 937
presence of thrombin, and in the presence of cPLA2i, thrombin
was unable to fully increase ATP-linked OCR (Figure 5F). This in-
dicates that cPLA2 activity is required for ATP-linked oxygen
consumption, both basally and on activation. Proton leak, calcu-
lated by subtracting OCR post-antimycin A from OCR post-
oligomycin, was unchanged in all groups (Figure 5F). Reserve
capacity was calculated by subtracting OCR before oligomycin
from OCR after FCCP. As shown recently, thrombin decreases
reserve capacity, since it is used to provide the mitochondrial
function for the increased energy demand during aggregation,
and we found this also occurred during cPLA2 inhibition, but to
a lesser extent (Figure 5F) (Ravi et al., 2015). cPLA2 inhibition
decreased reserve compared to basal (Figure 5F). Taken
together, these data show that blockade of cPLA2 decreases
mitochondrial electron transfer and lowers the cells’ ability to
respond to increased energetic demands. It is fully consistent
with a lower availability of energy-generating substrates in the
absence of sufficient FAs provided by cPLA2.
Glycolysis was measured as the extracellular acidification rate
(ECAR). We recently showed that 70% of the basal and
thrombin-stimulated ECAR is inhibited by 2-deoxy-D-glucose
(2DG), consistent with a high rate of glycolysis in platelets (Ravi
et al., 2015). Both the basal and thrombin-stimulated ECARs
were unchanged by cPLA2i (50 nM), indicating that they were
not influenced by lipid metabolism (Figure 5G).
Several Eicosanoids and FAs Act as Substrates for
Mitochondrial b-Oxidation during Platelet Activation
We sought to determine flux of eicosanoids and FAs through
b-oxidation in platelets using the carnitine palmitoyltransferase
inhibitor etomoxir, which prevents transfer of FA across the inner
mitochondrial membrane. Data are summarized in heatmaps
with bar charts as Supplemental Information (Figures 6A and
S6). In the resting platelet, increases in saturated and unsatu-
rated FAs upon etomoxir inhibition show that these are ongoing
b-oxidation substrates. However, thrombin-stimulated platelets
utilized these and many oxidized eicosanoids at higher rates,
as shown by the stronger response to etomoxir. Last, etomoxir
elevated eicosanoids less when cPLA2 was inhibited (Figures
6A and S6).
Platelet b-Oxidation and Glycolysis Are Required for FA
and Eicosanoid Elevations during Platelet Activation,
Representing a Positive Feedback Cycle Where Energy
Metabolism Is Required for Acute Lipidomic Flux
Next, we sought to determine eicosanoid and FA flux via
b-oxidation when glycolysis was blocked (glucose-free media +
2DG). Here, the expected thrombin-stimulated eicosanoid
burst was absent (Figures 6B and S7). Furthermore, etomoxir
failed to elevate eicosanoids or FAs, indicating that instead of
accelerated consumption, there was a failure to generate FAsFigure 4. Heatmaps and Network Analysis Showing the Diversity of Th
by Three Genetically Unrelated Donors
Heatmaps were generated using full-scan FTMS data for each donor using the
Levels of treatment response are represented by a color gradient ranging from b
Lipids are color-coded by group and clustered by similarity in overall response to
donor, pairwise correlations between lipids were calculated in R. Nodes repres
represents strength of correlation between nodes. Full data are available in Data
938 Cell Metabolism 23, 930–944, May 10, 2016and eicosanoids when energy production from glycolysis was
inhibited.
Blocking b-Oxidation Leads to Aminophospholipid
Externalization on the Platelet Surface
Since b-oxidation was recently shown to be required for full ag-
gregation, we instead determined whether it was required for an
additional energy-requiring pathway in platelets: maintenance of
phospholipid asymmetry (Ravi et al., 2015). In this, flippases and
floppases use ATP to keep PC on the outer leaflet of the plasma
membrane and aminophospholipids (aPLs), phosphatidylserine
(PS), and PE on the inner leaflet. Asymmetry is required for pre-
venting aPL externalization, an event that occurs during platelet
aggregation, apoptosis, and aging (storage lesion), supporting
thrombosis and platelet clearance. This is measured using An-
nexin V, which binds to the aPL headgroups. Over time, etomoxir
alone led to a small, but not significant, increase in aPL external-
ization, where glycolysis was able to compensate for blockade of
b-oxidation (Figure 6C). In contrast, when glycolysis was
blocked (glucose free medium + 2DG), large elevations in aPL
externalization were noted. These were significantly enhanced
by etomoxir, suggesting that b-oxidation is upregulated to
compensate for the lack of glycolysis. Collectively, these data
establish a functional link between b-oxidation/cPLA2 and
mitochondrial metabolism that further extends our knowledge
of how acute innate immune activation links to essential en-
ergy-requiring processes in platelets.
DISCUSSION
Currently, lipidomic approaches that simultaneously profile all
lipids in the cellular or tissue lipidome, while ensuring that
interfering artifact signals (e.g., isotopes, adducts, contami-
nating ions, and split-peak ions) have been thoroughly and
robustly removed, are not widely available. This has made
estimating the total lipidome in any mammalian cell extremely
difficult. Herein, we generated and applied new informatics
tools to address this gap. We estimated the total number
and diversity of lipids in platelets and structurally identified
many molecular species. An open resource is presented, al-
lowing further mining of the lipidome for potential transducers
of platelet-dependent activities, and it is described in more
detail below.
We recently showed that b-oxidation contributes to the extra
platelet energy demands that occur on activation (Ravi et al.,
2015). Herein, we demonstrate using etomoxir that the substrates
required for this are exclusively provided by cPLA2 (Figures 5D–
5F). This links platelet lipid mobilization to acute mitochondrial
bioenergetics and reveals a function for mitochondrial fatty
oxidation in modulating the cellular lipidome (Figure 6D). A dy-
namic cycle is revealed where, via cPLA2, platelets dramaticallyrombin and Aspirin Responses for Free and Oxidized FAs Generated
pheatmap package in R, and lipids are color-coded according to lipid group.
lue (decrease in response) to white (no change) to red (increase in response).
the treatments. Network analysis was done using Cytoscape 3.2.1. For each
ent individual lipids, and degree (size) is the number of links. Edge thickness
S6 for all individual lipids.
Figure 5. Thrombin-Stimulated Generation of FAs, Eicosanoids, OxPLs, and Mitochondrial Oxygen Consumption Is Sensitive to cPLA2 Inhi-
bition, while sPLA2 Inhibition Suppresses OxPLs Only
Heatmaps were generated using the pheatmap package in R and lipids color-coded according to lipid group. Levels of treatment response are represented by a
color gradient ranging from blue to red (increase in response). Lipids are color-coded by group and clustered by similarity in overall response to the treatments
(legend continued on next page)
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upregulate both FA release and oxidation as well as their removal
via b-oxidation on thrombin activation (Figure 6D). Several eicos-
anoids and FAs contributed to energy generation (Figures 6A and
6B).We note some apparent donor variability in terms ofwhich FA
and eicosanoidswere utilized (Figures 6A and 6B). Thismay relate
to differences in substrate supply for carnitine palmitoylacyltrans-
ferase between donors. Unexpectedly, when cPLA2 was inacti-
vated, fewer eicosanoids were subsequently removed through
b-oxidation (Figure S6, top). Thus, the ability of this pathway to
consume eicosanoids is highly sensitive to their generation rates
and thus, most likely, their availability as substrates.
When energy generation was blocked (via both glycolysis and
b-oxidation inhibition), levels of eicosanoids fell dramatically
(Figures 6B and S7). However, this was due to inhibition of their
generation and not their increased consumption. This reveals a
positive feedback loop where eicosanoid generation itself re-
quires energy, as well as a dynamic mechanism for removal of
eicosanoids that may also function to downregulate their
signaling actions. This unexpected finding may be due to the
requirement for ATP as a kinase substrate, e.g., for src tyrosine
kinases and mitogen-activated protein kinase that are activated
in response to thrombin upstream of cPLA2. Further studies are
required in order to delineate this. Conducting a global lipidomic
screen would determine whether this observation relates to lipi-
domic flux in general or is restricted to the effects on cPLA2 seen
herein. To our knowledge, energetic communication or coupling
between mitochondrial respiration and eicosanoid generation
has not been reported for any cell type. Of relevance, we note
that mitochondrial respiration and phosphorylation have been
observed to be functionally coupled for nuclear transport (Dzeja
et al., 2002).
To expand the functional relevance, the role of eicosanoids in
supporting energy-dependent maintenance of phospholipid
asymmetry in platelets via b-oxidation was characterized. Block-
ing b-oxidation inhibited asymmetry maintenance, particularly
when combined with glycolysis inhibition. This form of anergy
could be important if FA supply becomes limiting, e.g., at later
time points following activation of cells during inflammation/
injury, and may contribute to shutting down cell activities, pro-
moting coagulation and clearance of dying and apoptotic plate-
lets. We note that levels of lipids presented herein represent a
steady state, impacted by both generation and removal rates,
and thus do not provide information on total flux through the
pathway. Thus, the actual amounts mobilized and ultimately
used as substrate for energy generation are not yet known. It is
possible that a reliance on phospholipids tomeet energy require-
ments could deplete the cell of essential structural building
blocks. However, phospholipids are the predominant platelet
lipid class, and these cells are well known to undergo significant(A–C) Effect of PLA2 inhibitors on generation of FAs and oxPLs by platelets. Wash
using 0.2 U/mL thrombin for 30min and generation of lipids determined using LC/M
cPLA2, 50–100 nM cPLA2i; (B) iPLA2, 50 nM BEL; and sPLA2, 2 mMOOEPC. (C) In
fatty acid to aid data visualization. Results are shown as heatmaps, with full data
(D–G) cPLA2 inhibition suppressesmitochondrial oxygen consumption, but not gly
with cPLA2i (<200 nM) for 15min prior to bioenergetic measurements. (D) Basal OC
by 1 mg/mL oligomycin (O), 0.6 mM FCCP (F), and 10 mM antimycin A (Anti). (E) c
centage of control. (F) Indices of mitochondrial function, basal, thrombin responsi
OCR were calculated. (G) Basal and thrombin-responsive ECARs were calculated
representative donor, n = 3–5 replicates per sample. *p < 0.05, **p < 0.01, and **
940 Cell Metabolism 23, 930–944, May 10, 2016remodeling of their membranes during activation. Furthermore,
once trapped in a clot, they are considered to have mediated
their primary function and are ultimately removed by macro-
phage efferocytosis.
Our characterization is a much closer approximation com-
pared to previous studies of the total platelet lipidome (herein,
defining lipids as hydrophobic molecules extracted using stan-
dard lipidomic extraction protocols), in terms of basal size and
diversity, and represents a best estimate with the following limi-
tations: (1) instrument sensitivity may prevent all lipids being de-
tected; (2) despite major manual efforts, insufficient cleanup of
datasetsmay lead to some overestimation; (3) some lipid classes
are difficult to extract and analyze using standard methods and
maybe under-represented (e.g., some phosphoinositides, oxy-
sterols, and sphingolipids); and (4) the dataset may include
some unidentified species not classed as lipids (e.g., hydropho-
bic peptides). However, even with these limitations, we believe
our strategy offers a major step forward in defining the total lip-
idome of a mammalian cell and demonstrates several findings
about both diversity and dynamic changes in lipids during cell
activation and inhibition. Many lipids from the most abundant
classes were found, as well as thrombin-upregulated lipids in
the low-nanogram range (PGE2, PGD2, and esterified eicosa-
noids), validating both the coverage and sensitivity of the
approach. While several automated andmanual steps to remove
artifact ions were included, further optimization is still required.
For example, we are currently implementing a machine-learning
approach to parameter optimization that will further enhance
data quality, and consolidating LC analysis into a single
separation.
Given the size of lipidomics datasets, it is not feasible to struc-
turally validate every ion. Thus, we selected a smaller number of
ions for detailed structural characterization. We fully identified
and established triple-quadrupole-based assays for 111 oxPLs
and 81 FAs generated on thrombin activation, including several
that have never been detected before in platelets or other
mammalian cells. While a small number of oxPLs have been
found previously, we show that membrane PL oxidation is a far
more diverse and wide-ranging process in platelets than previ-
ously considered (Thomas et al., 2010). The most abundant
oxPLs containing HETEs are pro-coagulant both in vitro and
in vivo, through altering membrane charge and facilitating coag-
ulation factor binding at the cell surface (Thomas et al., 2010;
unpublished data). Thus, global oxidation of the unsaturated
platelet membrane PL pool is considerable, may support hemo-
stasis, and is analogous to the lipid whisker model proposed by
Hazen and colleagues whereby activatedmacrophages become
coated in oxPLs and visible to lipid scavenger receptors (Green-
berg et al., 2008).ed platelets were incubated with inhibitors or vehicle for 15 min, then activated
S/MS as described in Supplemental Information. Inhibitors were as follows: (A)
hibition of oxPLs by PLA2 inhibitors. oxPLs are grouped depending on the sn2
in Figures S3–S5.
colysis. Platelets were plated on Cell-Tak-coated XF96 plates, and pre-treated
R of platelets wasmeasured prior to injection of thrombin (0.5 U/mL), followed
PLA2i (0–200 nM) dose response of thrombin-linked OCR presented as a per-
ve, ATP-linked, proton leak, maximal, reserve capacity, and non-mitochondrial
from parallel ECAR measurements. Data expressed as mean ± SEM from one
*p < 0.005 different from control (ANOVA and Bonferroni post hoc test).
Figure 6. Eicosanoids and Fatty Acids Acutely Feed into b-Oxidation during Platelet Activation and Support Maintenance of Membrane
Phospholipid Asymmetry
Heatmaps were generated using the pheatmap package in R and lipids color-coded according to lipid group. Levels of treatment response are represented by a
color gradient ranging from blue (decrease in response) to white (no change) to red (increase in response). Lipids are color-coded by group and clustered by
similarity in overall response to the treatments.
(legend continued on next page)
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Three genetically unrelated donors showed considerable di-
versity in their basal and thrombin-stimulated lipidomes and re-
sponses to aspirin (Figures 1 and 4). Furthermore, one showed
far higher activation by thrombin in terms of the number or
amount of lipids generated (donor 3), while another showed far
less inhibition of the thrombin-stimulated lipid pool by aspirin
(donor 1), despite full blockade of the primary COX-1-derived ei-
cosanoids TX and 12-HHTrE. Low-dose aspirin is considered
platelet COX-1 selective, through acetylation of the active site.
However, many aspirin-inhibitable lipids, including FAs, are
generated via phospholipases upstream of COX-1. This under-
scores the importance of secondary activation as a positive
feedback mechanism during platelet-aggregation-associated
lipid mobilization. Specifically, COX-1-generated TXA2 activates
the thromboxane receptor (TP), inducing release of secondary
mediators such as ADP that then potentiate the thrombin-medi-
ated global lipidomic changes observed. We also noted aspirin
upregulation of FAs that was highly donor specific (Figure 4).
How lipid variations are controlled at a genetic and environ-
mental level is not understood and will require further study on
the lipidomes of large numbers of people and in different cells
or tissues. In particular, given the importance of aspirin as both
a cardioprotective and possible cancer therapeutic, a full under-
standing of how it regulates platelet lipids will be the focus of a
follow-up study with a larger number of volunteers. The stability
of the global lipidome with age, diet, and over time is unknown,
and the influence of external factors such as epigenetic control of
lipid-metabolizing enzymes could be considerable. Of rele-
vance, it was recently shown that cellular immune systems are
highly variable between individuals but remain remarkably con-
stant over time (Carr et al., 2016). Environmental factors were a
key influence, and during infection, transient changes were
observed that quickly reverted to baseline. Our understanding
of intra and inter-individual variability in terms human cell biology
of the immune and blood systems is in its infancy but currently a
major topic of research interest. Our study represents a first look
at a small group but importantly provides a platform for future
longitudinal studies of platelet lipidomics.
The platelet lipidome contains large numbers of species that
are absent from current databases (Figures S1A andS1C). These
included structures characterized herein, such 14-HDTE, HDTrE,
and HNDE, and many oxPLs. Most of the unknowns are above
1 kDa, and could include some classes absent from databases,
such as glycolipids (Figure 1D). Developing informatics work-
flows to assist with identification of specific families from these
large numbers of unknowns will be a major future endeavor.
The presence of 14-hydroxy C19 lipids was intriguing, since(A) Several eicosanoids are substrates for platelet b-oxidation on thrombin gen
temperature (RT), then activated using 0.2 U/mL thrombin at 37C for 30min and g
Information (n = 3). Inhibitors were as follows: etomoxir (Eto), 25 mM; cPLA2i, 100
(B) Inhibition of glycolysis leads to a failure to generate free fatty acids and eicosan
inhibitors or vehicle at RT, then activated using 0.2 U/mL thrombin at 37C for 3
Supplemental Information (n = 3). Cells were incubated in the presence or absen
glucose (2DG), 120 mM.
(C) Blocking b-oxidation leads to a failure to maintain phospholipid asymmetry in
240 min at RT, then stained for PS using Annexin V-FITC, for 15 min at RT in the
antimycin A (Anti), 10 mM; 2DG, 120 mM. Data were analyzed using one-way AN
vehicle and Eto+2DG with 2DG.
(D) Scheme for proposed role of cPLA2 in acutely feeding substrates into mitoch
942 Cell Metabolism 23, 930–944, May 10, 2016platelets contain no detectable C19 unsaturated substrate (Fig-
ure 3). They were largely inhibited by aspirin, suggesting they
originate via COX-1 (Data S1). Platelets generate significant
amounts of the C17 12-hydroxyheptadecatrienoic acid (12-
HHTrE) due to degradation of thromboxane A2 (TXA2), where
part of the prostanoid ring is lost (malondialdehyde), generating
the C17 monohydroxy lipid. We reasoned that platelets might
generate analogous lipids through metabolizing C22 substrates
with three, four, or five double bonds. Indeed, previous studies
found exogenous C22 substrate can be metabolized by COX
(Milks and Sprecher, 1985; Sprecher, 1986; Sprecher and Care-
aga, 1986); however, their generation from endogenous sub-
strate on agonist activation has never been shown. Analogous
lipids from 22:6 were not detected, and ions giving MS/MS frag-
mentation spectra consistent with resolvins, lipoxins (LXs), or
protectins were absent from our dataset. While some lipids
with parent m/z 351.2180 suggestive of lipoxins were detected
(Data S5 [p28] and Data S6 [p 15, top three bars]), their MS/
MS spectra were distinct from either LXA2 or B2. These were
highly sensitive to aspirin inhibition, indicating they likely origi-
nated via COX-1. We propose these to be additional prostanoids
based on the presence of some common daughter ions, but at
this stage, their structures are unknown. Thus, pro-resolvingme-
diators, including aspirin-triggered lipoxins, were not generated
by acutely activated platelets.
In summary, we surveyed the global diversity of human lipids
in a single cell type, including both knowns and unknowns and
to a high degree of sensitivity. We then used the information
to discover many lipids and link acute lipidomic changes with
metabolism. Specifically, cPLA2 blockade acutely decreased
b-oxidation and mitochondrial respiration, indicating a link be-
tween inflammatory signaling and regulation of the cellular me-
tabolome. These data represent the first full estimate of total lipid
molecular species for any cell type to date.EXPERIMENTAL PROCEDURES
Chemicals
These are provided in Supplemental Information.
Human Platelet Isolation, Activation, and Inhibition
For lipidomic studies, platelets were isolated from three genetically unrelated
healthy volunteers, as described in Supplemental Information. For baseline
samples, donors were free from nonsteroidal anti-inflammatory drugs for at
least 14 days and the study was approved by the Cardiff University School
of Medicine Ethics Committee (SMREC 12/13). For aspirinized samples, the
same donors were administered 75 mg/day aspirin for 7 days before donation.
For mitochondria experiments, platelets were isolated from concentrateseration. Washed platelets were incubated with inhibitors or vehicle at room
eneration of lipids determined using LC-MS/MS as described in Supplemental
nM.
oids on thrombin activation of platelets. Washed platelets were incubated with
0 min, with generation of lipids determined using LC-MS/MS as described in
ce of 5 mM glucose (Glc). Inhibitors were as follows: Eto, 25 mM; 2-deoxy-D-
platelets. Washed platelets were incubated with inhibitors or vehicle for up to
dark, and analyzed by flow cytometry. Inhibitors were as follows: Eto, 25 mM;
OVA with Bonferroni post hoc test (n = 3, mean ± SEM), comparing Eto with
ondrial oxidative phosphorylation and generation of oxPLs.
obtained from the blood bank by centrifugation then washed 23with PBS and
counted as described previously (Chacko et al., 2013). Collection and use of
these samples was approved by University of Alabama at Birmingham Institu-
tional Review Board.
Lipid Extraction
Lipids were extracted as described in Supplemental Information, resuspended
in 200 mL methanol and stored at 80C until analysis. For time course and
MRM experiments, internal standards (at 10 ng each of PGE2-d4, 12-HETE-
d8, DMPE, and DMPC) were added to the extraction solvent of time course
activation.
Global Lipidomics and Analysis of Lipids
Untargeted global analysis of lipids was performed, separately in positive- or
negative-ion mode, using LC coupled to an Orbitrap Elite mass spectrometer
(UPLC-Orbitrap Elite MS; Thermo Fisher Scientific). Lipids extracts were sepa-
rated on two different reverse-phase (RP) columns and gradient methods, as
described in Supplemental Information.
Targeted Analysis of Lipids
Selected lipids upregulated on thrombin activation in human platelets were
analyzed for temporal dynamics of their generation using LC-MS/MS (ABI
4000 or 6500 QTRAP) by monitoring precursor-to-product ion transitions in
MRM mode, as described in Supplemental Information.
Data Processing
Global scanning data, chromatographic alignment, peak or feature detection,
and isotopic filtering used SIEVE 2.0 (Thermo Fisher Scientific), as described in
Supplemental Information. SIEVE-aligned data were further processed using
in-house-generated software as described in Supplemental Information.
Statistical Analysis and Data Visualization
Treatment effect on donor grouping was projected using PCA from mixOmics
package in R. This dataset (features/mass ions common in two or more do-
nors) was scaled to unit variance (UV). Global distribution of features and
mass ions among donors was shown using VennDiagram in R (vennDiagram).
Radar plots were generated using Excel. Heatmaps were generated for each
donor using the pheatmap package in R, and lipids were color-coded accord-
ing to lipid group. Network analysis was done using Cytoscape 3.2.1. For each
donor, pairwise correlations between lipids were calculated in R. Due to the
high number of interactions, the network diagram shows only positive correla-
tions with a Pearson product-moment correlation coefficient value (r) > 0.9.
Structural Interpretation and Assignment of Lipids
Lipid species were putatively identified by matching their accurate mass to re-
cords in the following databases: (1) the HMDB (Wishart et al., 2013; http://
www.hmdb.ca/), (2) Lipidhome (Foster et al., 2013; http://www.ebi.ac.uk/
apweiler-srv/lipidhome/), (3) LipidMaps (Lipid Metabolites and Pathways
Strategy) (Sud et al., 2007; http://www.lipidmaps.org/), and (4) METLIN
(metabolite and tandem MS database) (Smith et al., 2005; http://metlin.
scripps.edu/) (as described in Supplemental Information).
Seahorse Extracellular Flux Analysis
Bioenergetic measurements of platelets were performed as previously des-
cribed (Chacko et al., 2013; Ravi et al., 2015). In brief, platelets suspended
in XF DMEM assay buffer (DMEM with 1 mM pyruvate, 5.5 mM D-glucose,
and 4 mM L-glutamine [pH 7.4]), were plated on Cell-Tak coated platelets
and then pre-incubated with cPLA2i (0–200 nM) for 15 min prior to the assay.
First basal bioenergetics were measured, followed by injection of either
thrombin (0.5 U/mL) or media, oligomycin (1 mg/mL), FCCP (0.6 mM), and anti-
mycin A (10 mM).
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